David S Hewings

7PUBLICATIONS
27CO-AUTHORS
GlycoconjugatesAutonomic nervous systemMolecular targetsGene and molecular therapyProteomics and intermolecular interactions (excl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 06, 2024
Expanding the repertoire of GalNAc analogues for cell-specific bioorthogonal tagging of glycoproteins.

Abdul Zafar, Sandhya Sridhar, Ganka Bineva-Todd

|Dec 13, 2023
Discovery of Orally Available and Brain Penetrant AEP Inhibitors.

Daniela Krummenacher, Weiping He, Bernd Kuhn

|Sep 30, 2022
Discovery of Novel Allosteric EGFR L858R Inhibitors for the Treatment of Non-Small-Cell Lung Cancer as a Single Agent or in Combination with Osimertinib.

Ulrike Obst-Sander, Antonio Ricci, Bernd Kuhn

|Nov 16, 2021
Preclinical Characterization of a Next-Generation Brain Permeable, Paradox Breaker BRAF Inhibitor.

Jürgen Wichmann, Caroline Rynn, Thomas Friess

|Mar 23, 2018
Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes.

David S Hewings, Johanna Heideker, Taylur P Ma

|Feb 15, 2017
Activity-based probes for the ubiquitin conjugation-deconjugation machinery: new chemistries, new tools, and new insights.

David S Hewings, John A Flygare, Matthew Bogyo

Pageof 2

Frequent Collaborators

2 joint publications

Bernd Kuhn

1 joint publications

Yvonne Alice Nagel

1 joint publications

Georg Jaeschke

1 joint publications

Farid El Oualid